Aigen Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,199
Closed -$77.8K 533
2025
Q4
$77.8K Sell
11,199
-27,461
-71% -$181K 0.02% 521
2025
Q3
$249K Buy
+38,660
New +$264K 0.04% 592
2025
Q2
Sell
-13,121
Closed -$84.9K 801
2025
Q1
$84.9K Sell
13,121
-9,195
-41% -$66.1K 0.01% 699
2024
Q4
$180K Buy
+22,316
New +$184K 0.03% 621
2024
Q3
Sell
-15,863
Closed -$111K 740
2024
Q2
$111K Buy
+15,863
New +$120K 0.02% 694
2022
Q4
Sell
-10,982
Closed -$76K 540
2022
Q3
$76K Sell
10,982
-10,065
-48% -$69.9K 0.01% 554
2022
Q2
$176K Buy
+21,047
New +$294K 0.03% 465
2022
Q1
Sell
-8,960
Closed -$226K 585
2021
Q4
$226K Buy
+8,960
New +$240K 0.01% 897
2020
Q1
Sell
-3,173
Closed -$95K 1271
2019
Q4
$95K Buy
+3,173
New +$82.5K 0.02% 693

Other funds holding BHC

Aigen Investment Management's BHC Position: Q1 2026 in Review

Aigen Investment Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 11,199 shares — an estimated $77.8K sold.

Aigen Investment Management first reported a position in BHC in Q4 2019 and held it in 9 quarters. The position peaked at $249K in Q3 2025. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Aigen Investment Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 11,199 Bausch Health shares in Q1 2026, an estimated $77.8K.
  • Aigen Investment Management first reported a position in Bausch Health in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's Bausch Health position peaked at $249K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.